Ad-interim 6- and 12-month results from a prospective multicenter investigation on Renzan Stent in the treatment of patients with femoro-popliteal disease in Tuscany (CURRENT Registry)

The Renzan™ stent demonstrated excellent early safety and efficacy outcomes in a challenging PAD population, with sustained mid-term patency despite a high proportion of complex lesions. These preliminary results support the use of this new mimetic stent design in real-world clinical settings and warrant further confirmation with longer-term follow-up.